Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 2Castration Resistant Metastatic Prostate Cancer 2Uterine Cervical Neoplasms 1Neoplasms 1Fatigue 1Castration-resistant Prostate Cancer 1Castration-Resistant Prostate Carcinoma 1Carcinoma, Squamous Cell 1Cachexia 1

Interventions

Megestrol Acetate 7Exercise 6Standard of Care 4Blood Specimen Collection 4Olanzapine 3Ibuprofen 3dermcidin 2Resistance Training 2Physical Therapy Modalities 2Nutrition Assessment 2Mirtazapine 2Melatonin 2Enteral Nutrition 2Diet Therapy 2Cyproheptadine 2testosterone enanthate 1telotristat ethyl 1remune 1olanzapine-fluoxetine combination 1nabiximols 1nabilone 1irinotecan sucrosofate 1fucoidan 1bermekimab 1anamorelin 1Vitamin D 1Ultrasonography 1Retrospective Studies 1Radiotherapy 1Powders 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cachexia × testosterone enanthate × Clear all
NCT00878995 2018-03-12

Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma

The University of Texas Medical Branch, Galveston

Phase 1 Completed
28 enrolled 55 charts
Gynecologic

Cachexia, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡